Intangible Assets
Intangible Assets
Intangible Assets
1) According to IAS 38 Intangible Assets, which of the following statements about research
and development expenditure are correct?
A. 1, 2 and 4 only
B. 1 and 3 only
C. 2 and 4 only
D. 3 and 4 only
2) According to IAS 38 Intangible Assets, which of the following statements concerning the
accounting treatment of research and development expenditure are TRUE?
A. 1 and 4
B. 2 and 4
C. 2 and 3
D. 1 and 3
3) Which of the following CANNOT be recognised as an intangible non-current asset in
NMB's statement of financial position at 30 September 20X1?
A. NMB spent $12,000 researching a new type of product. The research is expected to lead
to a new product line in 3 years' time
C. NMB purchased a brand name from a competitor on 1 November 20X0, for $65,000
D. NMB spent $21,000 during the year on the development of a new product. The product
is being launched on the market on 1 December 20X1 and is expected to be profitable
4) According to IAS 38 Intangible Assets, which of the following are intangible non-current
assets in the financial statements of Iota Co?
A. 1 and 3 only
B. 1, 2 and 3 only
C. 2 and 4 only
D. 2, 3 and 4 only
5) In its first year of trading to 31 July 20X6, Rigo Co incurred the following expenditure on
research and development, none of which related to the cost of non-current assets:
$10,000 on successfully devising processes for converting seaweed into chemicals X, Y and Z
and $90,000 on developing a headache pill based on chemical Z. No commercial uses have
yet been discovered for chemicals X and Y. Commercial production and sales of the
headache pill commenced on 1 April 20X6 and are expected to produce steady profitable
income during a 5-year period before being replaced. Adequate resources exist to achieve
this.
What is the maximum amount of development costs that must be carried forward at 31
July 20X6 under IAS 38 Intangible Assets?
A. $90,000
B. $84,000
C. $93,333
D. $72,000
6) A manufacturer incurs the following costs: $40,000 developing new techniques that will be
put in place shortly to cut production costs; $30,000 researching a new process to improve
the quality of the standard product and $5,500 on market research into the commercial
viability of a new type of product. It is company policy to capitalise costs whenever
permitted by IAS 38 Intangible Assets.
How much should be charged as research and development expenditure in profit or loss?
(ignore amortisation)
A. $75,500
B. $35,500
C. $70,000
D. $40,000
A. 1 and 2
B. 2 and 3
C. 3 and 4
D. 1 and 4
8) Dora Co purchased a patent on 31 December 20X3 for $300,000. Dora Co expects to use the
patent for ten years, after which it will be valueless.
According to IAS 38 Intangible Assets, what amount will be amortised in Alpha Co's
statement of profit or loss and other comprehensive income for the year ended 31
December 20X4?
$
9) QR purchased a quota for carbon dioxide emissions for $9,000 on 30 April 20X6 and
capitalised it as an intangible asset in its statement of financial position. QR estimates that
the quota will have a useful life of three years.
What is the journal entry required to record the amortisation of the quota in the
accounts for the year ended 30 April 20X9?
A. To allocate the cost of an intangible non-current asset over its useful life
B. To ensure that funds are available for the eventual purchase of a replacement non-
current asset
C. To reduce the cost of an intangible non-current asset in the statement of financial
position to its estimated market value
D. To account for the risk associated with intangible assets
11) Which of the following items (that all generate future economic benefits, and whose costs
can be measured reliably), is an intangible non-current asset?
Project 175 is investigating the link between vitamin deficiency and emotional well-being. If
a link is proven the company may produce a food additive to improve well-being.
Project 254 was completed during the year after a period of 15 months. It has achieved its
aim of reducing the material cost of a new product. Production of the product commenced
on 1 September 20X6. The first sales are expected in February 20X7 and the expected life of
the product is four years. The project meets the capitalisation criteria of IAS 38 Intangible
Assets.
A. $2.5 million
B. $7.3 million
C. $7.4 million
D. $8.9 million
13) Which of the following statements about intangible assets is/are true?
(1) All intangible assets should be reported in the statement of financial position
(2) Only purchased intangible assets can be reported in the statement of financial position
(3) Goodwill can only be carried in the statement of financial position at cost
A. Research
B. Franchise agreements
C. Internally generated goodwill
D. Staff expertise
E. Computer software
15) Which TWO of the following costs would be capitalised as intangible non-current assets?
Answers
2. C. Development costs are amortised over the useful life of the project. This is not confined
to five
years.
3. A. ABC spent $12,000 researching a new type of product. The research is expected to lead
to a
new product line in 3 years' time.
Research expenditure can never be capitalised and must be recognised as an expense in the
statement of profit or loss in accordance with IAS 38.
4. B. A factory is a tangible asset as it has physical form. The others are intangible assets.
5. B. $84,000
The $10,000 spent on converting seaweed does not meet the recognition criteria for an
intangible asset and so must be recognised as an expense in profit or loss.
The $90,000 relating to the headache pill must be capitalised. Amortisation must start once
commercial production begins and amortisation is $1,500 per month ($90,000 / 5 years).
The value at the year end represents $90,000 less four months' amortisation.
6. B. $35,500
The $30,000 research costs are not directed towards a confirmed outcome and so should be
recognised as an expense. The $5,500 market research costs suggest that the commercial
viability of the product has not yet been determined and so the capitalisation criteria have not
yet
been satisfied.
7. B. 2 and 3
The benefits flowing from the completed development are expected to be less than its cost
Funds are unlikely to be available to complete the development
The company must have adequate resources to fund the project for it to be capitalised.
8. $30,000
The patent should be amortised over its useful life of 10 years. (300,000 / 10) = $30,000
9. B. The amortisation charge is $9,000/3 years = $3,000 per annum. The double entry to
record
the amortisation is DEBIT expenses, CREDIT accumulated amortisation.
10. A. Amortisation is an application of the matching concept and allocates the cost of the
intangible
asset over its useful life (over the accounting periods expected to benefit from its use).
11. D. A patent has no physical substance and provides future economic benefits; it is
therefore an
intangible non-current asset.
Operating software that operates the computer hardware on first glance may appear to be an
intangible non-current asset. However, since it is an integral part of the computer hardware
(which could not function without it), it is classed as part of the computer hardware.
A building extension has physical substance and provides future economic benefits and is
therefore a tangible non-current asset.
12. C. Expenditure on both Projects 175 and 393 is research expenditure which must be
expensed as incurred.
(3) Is incorrect. Goodwill (like any other asset) must be carried at an amount
that is less than cost if its realisable amount is less than cost.
14. B and E
Research is specifically disallowed by IAS 38 because an asset should be capable of bringing
economic benefit and be reliably measured. Uncertainty exists as to whether the research will
bring future economic benefit.
Only purchased goodwill can be recognised. Therefore the answer internally generated
goodwill is incorrect.
A company cannot control staff nor can a value be reliably measured. Therefore the answer 'staff
expertise' is incorrect.
15. A and C
Option (A) and option (C) are both intangible because neither have a physical form and both have an
economic value to the business.
Option (B) is an expense because it will be used within six months, whereas assets are used in the
business for over a year
Option (D) relates to a tangible asset, property, not an intangible asset.